Yunxiang Ling

Yunxiang Ling

Auto-generated profile, based on publicly available information

Yunxiang Ling

Department of Physiology and Pathophysiology, Health Science Center, Ningbo University, Ningbo, Zhejiang, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2025 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
TRTingting Ruan
Tingting Ruan
YLYunxiang Ling
Yunxiang Ling
CWCan Wu
Can Wu
YNYanfang Niu
Yanfang Niu
GLGuili Liu
Guili Liu
SXShujun Xu
Shujun Xu
Background: Abnormal lipid metabolism has been identified as a potential pathogenic mechanism of Alzheimer's disease (AD), which might be epigenetically regulated. Lysosomes are critical organelles for lipid metabolism. However, the epigenetic modifications of lysosome and lipid regulating genes remain unclear in AD patients. Objective: Explore the role of abnormal epigenetic modifications, especially methylation of lysosome and lipid metabolism-related genes in AD. Methods: Methylation beadchip and MALDI-TOF mass spectrometry were used to detect genome-wide DNA methylation levels and validate key gene methylation, respectively. Clinical data were collected from all participants. Associations between clinical biochemical characteristics and altered DNA methylation in AD patients were analyzed, and a risk factor model of AD was established. Results: 41 differentially methylated positions (DMPs) corresponding to 33 genes were identified in AD patients, with 18 hypermethylated and 23 hypomethylated positions. Significant alterations were observed in lipid regulating genes ( CTNNB1, DGKQ, SLC27A1 ) and lysosomal transmembrane gene ( TMEM175 ). Clinical analysis revealed that TP, ALB, IB, ADA, ALP, HCY, GLU, TC, BUN, HDL-C, LDL-C, and APOA1 levels were significantly higher in AD patients, whereas A/G and DB levels were lower. TMEM175 hypermethylation was further verified and found to correlate with TC, HDL-C, LDL-C, APOA1, IB, and HCY. The AUC of the AD risk model, which integrated clinical lipid markers and TMEM175 methylation, reached 0.9519 ( p  < 0.0001). Conclusions: Abnormal epigenetic regulation of lysosomal gene and lipid dyshomeostasis were high-risk factors in AD. Methylation modifications of lysosome and lipid regulating genes might be key processes in AD pathogenesis.